FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip

Abstract

The COVID-19 pandemic originating in the Wuhan province of China in late 2019 has impacted global health, causing increased mortality among elderly patients and individuals with comorbid conditions. During the passage of the virus through affected populations, it has undergone mutations, some of which have recently been linked with increased viral load and prognostic complexities. Several of these variants are point mutations that are difficult to diagnose using the gold standard quantitative real-time PCR (qRT-PCR) method and necessitates widespread sequencing which is expensive, has long turn-around times, and requires high viral load for calling mutations accurately. Here, we repurpose the high specificity of Francisella novicida Cas9 (FnCas9) to identify mismatches in the target for developing a lateral flow assay that can be successfully adapted for the simultaneous detection of SARS-CoV2 infection as well as for detecting point mutations in the sequence of the virus obtained from patient samples. We report the detection of the S gene mutation N501Y (present across multiple variant lineages of SARS-CoV2) within an hour using lateral flow paper strip chemistry. The results were corroborated using deep sequencing on multiple wild type (n=37) and mutant (n=22) viral RNA samples with a sensitivity of 87% and specificity of 97%. The design principle can be rapidly adapted for other mutations (as shown also for E484K and T716I) highlighting the advantages of quick optimization and roll-out of CRISPR diagnostics (CRISPRDx) for disease surveillance even beyond COVID-19. This study was funded by Council for Scientific and Industrial Research, India.

Data availability

Sequencing data associated with the manuscript have been deposited to GISAID with the following numbers:EPI_ISL_911542, EPI_ISL_911532, EPI_ISL_911543, EPI_ISL_911533, EPI_ISL_911544, EPI_ISL_911534, EPI_ISL_911545, EPI_ISL_911535, EPI_ISL_911546, EPI_ISL_911536, EPI_ISL_911547, EPI_ISL_911537, EPI_ISL_911538, EPI_ISL_911540, EPI_ISL_911541, EPI_ISL_911539 were just released and are now available to all participants in GISAID.

Article and author information

Author details

  1. Manoj Kumar

    in, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0772-1399
  2. Sneha Gulati

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  3. Asgar H Ansari

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  4. Rhythm Phutela

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  5. Sundaram Acharya

    IGIB, CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    No competing interests declared.
  6. Mohd Azhar

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    Mohd Azhar, Mohd. Azhar is currently an employee of TATA Medical and Diagnostics.
  7. Jayaram Murthy

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  8. Poorti Kathpalia

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  9. Akshay Kanakan

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  10. Ranjeet Maurya

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  11. Janani Srinivasa Vasudevan

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3381-5228
  12. Aparna Murali

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  13. Rajesh Pandey

    CSIR Ayurgenomics Unit (TRISUTRA), CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    No competing interests declared.
  14. Souvik Maiti

    Chemical and Systems Biology, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India
    For correspondence
    souvik@igib.res.in
    Competing interests
    No competing interests declared.
  15. Debojyoti Chakraborty

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    For correspondence
    debojyoti.chakraborty@igib.in
    Competing interests
    Debojyoti Chakraborty, A patent application has been filed in relation to this work. (0127NF2019)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1460-7594

Funding

University Grants Commission (Graduate student fellowship)

  • Manoj Kumar

IUSSTF (CLP-0033)

  • Rajesh Pandey

CSIR Sickle Cell Anemia Mission (HCP0008)

  • Debojyoti Chakraborty

Tata Steel (SSP 2001)

  • Debojyoti Chakraborty

Lady Tata Young Investigator (GAP0198)

  • Debojyoti Chakraborty

CSIR Sickle Cell Anemia Mission (HCP0008)

  • Souvik Maiti

CSIR (Graduate Student fellowship)

  • Mohd Azhar

CSIR (Graduate Student fellowship)

  • Jayaram Murthy

CSIR (Research Associateship)

  • Sneha Gulati

Indian Council of Medical Research (Graduate Student fellowship)

  • Asgar H Ansari

CSIR (Graduate Student fellowship)

  • Rhythm Phutela

CSIR (Graduate Student fellowship)

  • Sundaram Acharya

CSIR (Research Associateship)

  • Poorti Kathpalia

CSIR (MLP 2005)

  • Rajesh Pandey

Fondation Botnar (CLP-0031)

  • Rajesh Pandey

Intel Corporation (CLP-0034)

  • Rajesh Pandey

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The present study was approved by the Ethics Committee, Institute of Genomics and Integrative Biology, New Delhi (CSIR-IGIB/IHEC/2020-21/01.)

Copyright

© 2021, Kumar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,397
    views
  • 759
    downloads
  • 61
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Manoj Kumar
  2. Sneha Gulati
  3. Asgar H Ansari
  4. Rhythm Phutela
  5. Sundaram Acharya
  6. Mohd Azhar
  7. Jayaram Murthy
  8. Poorti Kathpalia
  9. Akshay Kanakan
  10. Ranjeet Maurya
  11. Janani Srinivasa Vasudevan
  12. Aparna Murali
  13. Rajesh Pandey
  14. Souvik Maiti
  15. Debojyoti Chakraborty
(2021)
FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip
eLife 10:e67130.
https://doi.org/10.7554/eLife.67130

Share this article

https://doi.org/10.7554/eLife.67130

Further reading

    1. Epidemiology and Global Health
    Marina Padilha, Victor Nahuel Keller ... Gilberto Kac
    Research Article Updated

    Background:

    The role of circulating metabolites on child development is understudied. We investigated associations between children’s serum metabolome and early childhood development (ECD).

    Methods:

    Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children’s milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥1. The interaction between significant metabolites and the child’s age was tested.

    Results:

    Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child’s nutritional status, diet quality, and infant age. Cresol sulfate (β=–0.07; adjusted-p <0.001), hippuric acid (β=–0.06; adjusted-p <0.001), phenylacetylglutamine (β=–0.06; adjusted-p <0.001), and trimethylamine-N-oxide (β=–0.05; adjusted-p=0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged –1 SD: β=–0.05; pP=0.01;+1 SD: β=0.05; p=0.02) and methylhistidine (–1 SD: β = - 0.04; p=0.04;+1 SD: β=0.04; p=0.03).

    Conclusions:

    Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.

    Funding:

    Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Gillian AM Tarr, Linda Chui ... Tim A McAllister
    Research Article

    Several areas of the world suffer a notably high incidence of Shiga toxin-producing Escherichia coli. To assess the impact of persistent cross-species transmission systems on the epidemiology of E. coli O157:H7 in Alberta, Canada, we sequenced and assembled E. coli O157:H7 isolates originating from collocated cattle and human populations, 2007–2015. We constructed a timed phylogeny using BEAST2 using a structured coalescent model. We then extended the tree with human isolates through 2019 to assess the long-term disease impact of locally persistent lineages. During 2007–2015, we estimated that 88.5% of human lineages arose from cattle lineages. We identified 11 persistent lineages local to Alberta, which were associated with 38.0% (95% CI 29.3%, 47.3%) of human isolates. During the later period, six locally persistent lineages continued to be associated with human illness, including 74.7% (95% CI 68.3%, 80.3%) of reported cases in 2018 and 2019. Our study identified multiple locally evolving lineages transmitted between cattle and humans persistently associated with E. coli O157:H7 illnesses for up to 13 y. Locally persistent lineages may be a principal cause of the high incidence of E. coli O157:H7 in locations such as Alberta and provide opportunities for focused control efforts.